Atossa files for third IPO try

Atossa Genetics Inc. (Seattle, Wash.) filed an IPO for the third time and proposed to sell up to 1 million shares at $5-$7 in an offering underwritten by Dawson James Securities on NASDAQ. If sold in full at the midpoint of $6, the company would raise $6 million and be valued at $73.5 million. Atossa previously withdrew IPO filings in 2010 and 2011, the most recent of which offered up to 3 million units at $5-$7 on the NYSE Amex (see BioCentury Extra, Feb. 15, 2011). ...